Fourteen-Year Anti-TNF Therapy in Crohn’s Disease Patients: Clinical Characteristics and Predictive Factors

被引：0
|
作者：
Aisaku Osamura
Yasuo Suzuki
机构：
[1] Toho University,Department of Internal Medicine, Sakura Medical Center
来源：
Digestive Diseases and Sciences | 2018年 / 63卷
关键词：
Crohn’s disease; Loss of response; Infliximab; Adalimumab; Risk factor;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：204 / 208
页数：4
相关论文
共 50 条
  • [21] Efficacy of anti-TNFα drugs in patients with stricturing Crohn's disease
    D'Amico, Ferdinando
    Pugliese, Nicola
    Peyrin-Biroulet, Laurent
    Danese, Silvio
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2020, 14 (05) : 347 - 353
  • [22] Effectiveness of Adalimumab in Perianal Fistulas in Crohn's Disease Patients Naive to Anti-TNF Therapy
    Castano-Milla, Carlos
    Chaparro, Maria
    Saro, Cristina
    Barreiro-de Acosta, Manuel
    Garcia-Albert, Ana M.
    Bujanda, Luis
    Martin-Arranz, Maria D.
    Carpio, Daniel
    Munoz, Fernando
    Mancenido, Noemi
    Garcia-Planella, Esther
    Piqueras, Marta
    Calvet, Xavier
    Cabriada, Jose L.
    Botella, Belen
    Bermejo, Fernando
    Gisbert, Javier P.
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2015, 49 (01) : 34 - 40
  • [23] Clinical Impact of Sonographic Transmural Healing After Anti-TNF Antibody Treatment in Patients with Crohn's Disease
    Maria Paredes, Jose
    Moreno, Nadia
    Latorre, Patricia
    Ripolles, Tomas
    Jesus Martinez, Maria
    Vizuete, Jose
    Moreno-Osset, Eduardo
    DIGESTIVE DISEASES AND SCIENCES, 2019, 64 (09) : 2600 - 2606
  • [24] Safety and Efficacy of Anti-TNFα Treatment in Crohn's Disease Patients with Abdominal Abscesses
    Ibanez-Samaniego, Luis
    Diaz-Fontenla, Fernando
    Miranda-Bautista, Jose
    Acosta, Carmen
    Barcelo, Irene
    Flores, Virginia
    Echenagusia, Mikel
    Camunez, Fernando
    Diaz-Redondo, Alicia
    Marin-Jimenez, Ignacio
    Menchen, Luis
    HEPATO-GASTROENTEROLOGY, 2015, 62 (139) : 647 - 652
  • [25] Predictive biomarkers for anti-TNF alpha therapy in IBD patients
    Kumar, Manoj
    Murugesan, Selvasankar
    Ibrahim, Nazira
    Elawad, Mamoun
    Al Khodor, Souhaila
    JOURNAL OF TRANSLATIONAL MEDICINE, 2024, 22 (01)
  • [26] Predictive biomarkers for anti-TNF alpha therapy in IBD patients
    Manoj Kumar
    Selvasankar Murugesan
    Nazira Ibrahim
    Mamoun Elawad
    Souhaila Al Khodor
    Journal of Translational Medicine, 22
  • [27] Interstitial lung disease occurring under anti-TNFα therapy for Crohn's disease
    Rkiouak, A.
    Reggad, A.
    Akhouad, Y.
    Kasmy, Z.
    Boudlal, M.
    Nait Lho, A.
    Rabhi, M.
    Radouane, B.
    Ennibi, K.
    Chaari, J.
    REVUE FRANCAISE D ALLERGOLOGIE, 2014, 54 (07): : 500 - 504
  • [28] Anti-TNF and Crohn's Disease: When Should We Stop?
    Louis, Edouard
    Belaiche, Jacques
    Reenaers, Catherine
    CURRENT DRUG TARGETS, 2010, 11 (02) : 148 - 151
  • [29] Anti-TNF therapy is associated with a reduction in radiation exposure in patients with Crohn's disease
    Aggarwal, Divya
    Limdi, Jimmy K.
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2015, 27 (01) : 13 - 19
  • [30] Identification of inflammatory mediators in patients with Crohn's disease unresponsive to anti-TNFα therapy
    Franco Leal, Raquel
    Planell, Nuria
    Kajekar, Radhika
    Lozano, Juan J.
    Ordas, Ingrid
    Dotti, Isabella
    Esteller, Miriam
    Carme Masamunt, M.
    Parmar, Harsukh
    Ricart, Elena
    Panes, Julian
    Salas, Azucena
    GUT, 2015, 64 (02) : 233 - 242
12345